Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages.

Cancers (Basel) · 2020 · PMC7226444 · PMID 32290637

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A combination of the five best markers at each time point resulted in highly significant marker panels indicating therapeutic response (R 2 = 0.78, R 2 = 0.71, and R 2 = 0.71).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.